TTPH at these prices, I doubt I'll bother reacquainting myself . . . things that make you go "hmmm."
Rockrat, I took a tiny position in TTPH before the fall, knowing that a binary event was coming. Obviously the event was negative, but I had reported that this co. looked good from a management standpoint, funding standpoint and technology standpoint, so I held and waited for this move off the bottom. I am reasonably certain that they will have the results necessary for an NDA sometime this or next year, and new tetracycline antibiotics (and a platform for mass production AND introducing variant formulae for future drugs) are all attractive to my risk/benefit tolerance.
